Long-term safety and efficacy of the fully human CAR-T therapy CT103A in relapsed/refractory multiple myeloma
Author:
Qiuxia Yu,Di Wang,Zhe Li,Ning An,Chunhui Li,Yuhan Bao,Xinyu Wen,Xiaolu Long,Jue Wang,Lijun Jiang,Wei Mu,Peiling Zhang,Chang Shu,Huan Ye,Hongyu Gui,Songbai Cai,Guang Hu,Wen Wang,Aihua Du,Chunrui Li
Publication:
Molecular Therapy
© 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.